BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 15140551)

  • 21. A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606).
    Kunitoh H; Tamura T; Shibata T; Takeda K; Katakami N; Nakagawa K; Yokoyama A; Nishiwaki Y; Noda K; Watanabe K; Saijo N;
    Br J Cancer; 2010 Jun; 103(1):6-11. PubMed ID: 20551960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.
    Mornex F; Resbeut M; Richaud P; Jung GM; Mirabel X; Marchal C; Lagrange JL; Rambert P; Chaplain G; Nguyen TD
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):651-9. PubMed ID: 7790251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy of invasive thymoma. A retrospective study of 22 cases.
    Göldel N; Böning L; Fredrik A; Hölzel D; Hartenstein R; Wilmanns W
    Cancer; 1989 Apr; 63(8):1493-500. PubMed ID: 2466548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up.
    Lucchi M; Melfi F; Dini P; Basolo F; Viti A; Givigliano F; Angeletti CA; Mussi A
    J Thorac Oncol; 2006 May; 1(4):308-13. PubMed ID: 17409875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.
    Kirzinger L; Boy S; Marienhagen J; Schuierer G; Neu R; Ried M; Hofmann HS; Wiebe K; Ströbel P; May C; Kleylein-Sohn J; Baierlein C; Bogdahn U; Marx A; Schalke B
    PLoS One; 2016; 11(12):e0168215. PubMed ID: 27992479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial.
    Korst RJ; Bezjak A; Blackmon S; Choi N; Fidias P; Liu G; Marx A; Wright C; Mock S; Rutledge JR; Keshavjee S
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):36-44, 46.e1. PubMed ID: 24139613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors.
    Wright CD; Choi NC; Wain JC; Mathisen DJ; Lynch TJ; Fidias P
    Ann Thorac Surg; 2008 Feb; 85(2):385-9. PubMed ID: 18222230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.
    Loehrer PJ; Kim K; Aisner SC; Livingston R; Einhorn LH; Johnson D; Blum R
    J Clin Oncol; 1994 Jun; 12(6):1164-8. PubMed ID: 8201378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma.
    Macchiarini P; Chella A; Ducci F; Rossi B; Testi C; Bevilacqua G; Angeletti CA
    Cancer; 1991 Aug; 68(4):706-13. PubMed ID: 1855170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.
    Kim BK; Cho BC; Choi HJ; Sohn JH; Park MS; Chang J; Kim SK; Kim DJ; Chung KY; Lee CG; Kim JH; Yoo NC
    Oncol Rep; 2008 Jun; 19(6):1525-31. PubMed ID: 18497960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy of invasive or metastatic thymoma: report of 11 cases.
    Fornasiero A; Daniele O; Sperandio P; Morandi P; Fosser VP; Cartei G; Fiorentino MV
    Cancer Treat Rep; 1984 Oct; 68(10):1205-10. PubMed ID: 6543151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of chemotherapy in the management of advanced thymic tumors.
    Evans TL; Lynch TJ
    Semin Thorac Cardiovasc Surg; 2005; 17(1):41-50. PubMed ID: 16104360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
    Kong L; Zhang YW; Hu CS; Guo Y
    Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodality therapy for thymoma patients with pleural dissemination.
    Nakamura S; Kawaguchi K; Fukui T; Hakiri S; Ozeki N; Mori S; Goto M; Hashimoto K; Ito T; Yokoi K
    Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):524-529. PubMed ID: 30725276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy for invasive thymoma. A 13-year experience.
    Fornasiero A; Daniele O; Ghiotto C; Piazza M; Fiore-Donati L; Calabró F; Rea F; Fiorentino MV
    Cancer; 1991 Jul; 68(1):30-3. PubMed ID: 2049749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide followed by surgery for thymic carcinoma.
    Kawasaki H; Taira N; Ichi T; Yohena T; Kawabata T; Ishikawa K
    Eur J Surg Oncol; 2014 Sep; 40(9):1151-5. PubMed ID: 24703656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
    Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal treatment for stage IVA thymoma: a proposable strategy.
    Rena O; Mineo TC; Casadio C
    Lung Cancer; 2012 Apr; 76(1):89-92. PubMed ID: 22030450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.